Replies to post #121324 on Anavex Life Sciences Corp (AVXL)

[Bourbon_on_my_cornflakes]

Really interesting Mike. It does make you wonder if maybe we will see one big combined trial with alz, Rett, parkinsons and MS patients that would lead to a blanket approval for all these indications as long as the particular subgroup responded.

This would significantly lower the risk of the trial as hitting positive results for at least one indication is quite likely, and you would only have to hit one out of four to get 273 approved.